CAPSTONE INVESTMENT ADVISORS, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 245 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2022$1,077,741
+6.3%
13,7030.0%0.01%
+33.3%
Q3 2022$1,014,000
+13.5%
13,7030.0%0.01%
+50.0%
Q2 2022$893,000
+3.1%
13,7030.0%0.00%
+100.0%
Q1 2022$866,000
+19.1%
13,7030.0%0.00%
+100.0%
Q4 2021$727,000
-24.8%
13,7030.0%0.00%
-50.0%
Q3 2021$967,000
+41.2%
13,703
+33.3%
0.00%0.0%
Q2 2021$685,000
-73.4%
10,277
-55.7%
0.00%
-75.0%
Q1 2021$2,575,000
+781.8%
23,200
+212.9%
0.01%0.0%
Q2 2017$292,0007,4140.01%
Other shareholders
HAEMONETICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders